Navigation Links
Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse
Date:12/14/2009

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ -- Following is a statement by Linda A. Suydam, D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding today's release of the National Institute on Drug Abuse's (NIDA's) Monitoring the Future survey:

"Findings released today on this year's Monitoring the Future survey speak to the need for continued efforts to educate and empower parents with the information they need to talk to their teens about medicine abuse. The Consumer Healthcare Products Association (CHPA) believes these findings serve as a reminder of the importance of education and talking to teens about the dangers of over-the-counter (OTC) cough medicine abuse. While we are pleased to see that rates of cough medicine abuse have not increased in the past year, consistency is key in the effort to educate teens about the dangers of medicine abuse. CHPA wants to remind parents to continue to maintain an ongoing dialogue with their teens to prevent the risk of medicine abuse affecting their family. The leading makers of OTC cough medicines will continue their commitment to engage parents and raise awareness about the dangers of the abuse of cough medicines containing the active ingredient, dextromethorphan. The Monitoring the Future study is conducted out of the University of Michigan and is considered one of the preeminent teen substance abuse surveys in the United States.

"Since 2003, CHPA and the leading makers of OTC cough medicines have been engaged in a multi-pronged public health education campaign to raise awareness about the dangers of abusing OTC cough medicines. Teens looking to get high take excessive amounts--sometimes 25 to 50 times the recommended dosage of dextromethorphan. Often, they are abusing cough medicines with other prescription drugs and alcohol. The campaign has grown to include a number of key partners, including the Partnership for a Drug-Free America, the Community Anti-Drug Coalitions of America, D.A.R.E. America, and WebMD. In addition to our education agenda, CHPA also advocates for a federal law to prohibit the sale of dextromethorphan-containing cough medicines to those under the age of 18 as an added tool for parents to help prevent teen cough medicine abuse.

"CHPA's work to prevent teen cough medicine abuse is comprehensive, and includes lesson plans for school-aged children, toolkits to spark community involvement, and an online resource at StopMedicineAbuse.org to educate parents and other teen influencers and enlist them to help spread the word. The latest advancement in the overall campaign is the introduction of a new educational icon presented on the packaging of most OTC cough medicines containing dextromethorphan. This icon serves as a mini public service announcement for parents, making them aware of the issue of cough medicine abuse among teens, and pointing them to StopMedicineAbuse.org where they can access the resources they need to talk to their teens about the issue.

"Parents have far more power than they realize to keep their kids drug-free. Teens who learn a lot about the dangers of drug abuse from their parents are up to half as likely to abuse drugs. Even if their teens don't have an issue, parents need to realize that their children live in a world where the issue exists.

"We continue to encourage parents to visit StopMedicineAbuse.org and:

  1. Educate themselves about the problem of medicine abuse among teens.
  2. Share what they learn with other parents in their community.
  3. Talk to their teens about substance abuse, including cough medicine abuse.
  4. Safeguard and take a regular inventory of home medicine cabinets.
  5. Monitor their teen's Internet use for sites that offer information supporting the inappropriate use or abuse of medicines.
  6. Seek the help of a professional if they think their child has a substance abuse problem."

CHPA is the 128-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.

www.chpa-info.org

SOURCE Consumer Healthcare Products Association


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
2. Statement From The National Conclave on HIV/AIDS Policy for Black Clergy
3. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Statement of Andrea Kavanagh, Director, Pure Salmon Campaign, on the Science Sea Lice Study
6. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
7. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
8. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
9. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
10. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
11. VA Statement on Smoking Cessation Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... TEL AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. ... and immunology, today reports its financial results for the ... and achievements during the second quarter 2017 and to ... on multiple clinical development programs for the Company,s lead ... Phase 3 pivotal study with BL-8040 as novel stem ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... Blue Health Intelligence (BHI) announced today ... Officer. Dr. Spiro brings over 30 years of clinical, healthcare IT, value-based care, and ... analytics solutions. , “I am thrilled to welcome Dr. Spiro to BHI,” said ...
(Date:8/16/2017)... ... 16, 2017 , ... The Data Council, the leading provider ... acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the Specialty, ... leading suppliers, brokers, distributors and retailers. The Data Council will become a part ...
(Date:8/16/2017)... York, New York (PRWEB) , ... August 16, 2017 , ... ... they could minimize its appearance with diet and exercise. In fact, cellulite can't always ... is a safer and more effective treatment available to select physicians nationwide. Dr. Kenneth ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern ... three-year grant totaling $975,000, renewing its funding from the Health Resources and Services ... This funding marks, the fourth time the HRSA administration has renewed its financial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... With a new ... and ultimately, a cure. , The grants are awarded through a competitive application ... with a wide array of backgrounds and expertise in all areas relevant to PD ...
Breaking Medicine News(10 mins):